Concepedia

Jinee Rizzo

JR

Statistics

Publications

21

Citations

2.2K

H-Index

17

Active since

1982

Affiliations

The University of Texas at San Antonio Health Science Center(Current)

The University of Texas at Austin

Brooke Army Medical Center

Murphy Oil Corporation (United States)

Wilford Hall Ambulatory Surgical Center

Jinee Rizzo is an author at The University of Texas at San Antonio Health Science Center specializing in pharmacology, cancer pharmacology, and pharmacokinetics of anticancer drugs.

Publications per year

1982–2005

21

Publications

21

Phase I and Pharmacologic Study of OSI-774, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Malignancies

Manuel Hidalgo, Lillian L. Siu, John Nemunaitis et al. · Journal of Clinical Oncology · 2001 · 1K citations

, , +15

A phase I trial of taxol given by a 6-hour intravenous infusion.

T.D. Brown, Kathleen A. Havlin, Geoffrey R. Weiss et al. · Journal of Clinical Oncology · 1991 · 182 citations

, , +17

Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report.

Susan M. Chang, John G. Kuhn, Jinee Rizzo et al. · Journal of Clinical Oncology · 1998 · 166 citations

, , +17

A Phase I and Pharmacokinetic Study of Pegylated Camptothecin as a 1-Hour Infusion Every 3 Weeks in Patients With Advanced Solid Malignancies

Eric K. Rowinsky, Jinee Rizzo, Leonel Ochoa et al. · Journal of Clinical Oncology · 2002 · 132 citations

, , +17

Pharmacodynamic evaluation of the epidermal growth factor receptor inhibitor OSI-774 in human epidermis of cancer patients.

Shazli N. Malik, Lillian L. Siu, Eric K. Rowinsky et al. · PubMed · 2003 · 130 citations

, , +17

1–5 of 21